fda tirzepatide injection shortage resolved oct 2 2024 says the weight-loss drug is over FDA backtracks over Eli Lilly

This leads to: Glycosuria: lowers plasma glucose levels

In the trial, people on the Wegovy pill lost about 13.6% of their body weight, while people on a placebo lost about 2% after 71 weeks

Side Effects The most common tirzepatide side effects include abdominal pain, burping, constipation, diarrhea, dyspepsia, fatigue, gastroesophageal reflux disease, hair loss, hypersensitivity reactions, injection site reactions, nausea, and vomiting, which affects 5% or more patients

For some patients, that alone is enough to make the drug feel more realistic than a shot ever did

Understanding these differences underscores the importance of accurate dosing